SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Aug-24 6:46 PM View: | Tscan Therapeutics, Inc. (TCRX) | 23-Aug-24 | Option Exercise | 157,186 | $3.38 | $531,520.00 | 1287% 12.22K to 169.4K | |
27-Aug-24 6:46 PM View: | Tscan Therapeutics, Inc. (TCRX) | 23-Aug-24 | Option Sale | 157,186 | $5.78 | $908,755.00 | (93%) 169.4K to 12.22K | |
27-Aug-24 6:46 PM View: | Tscan Therapeutics, Inc. (TCRX) | 23-Aug-24 | Sale | 7,500 | $5.78 | $43,360.50 | (61%) 12.22K to 4.72K | |
27-Sep-21 5:22 PM View: | Tscan Therapeutics, Inc. (TCRX) | 23-Sep-21 | Market Purchase | 4,716 | $7.48 | $35,255.40 | 100% 0 to 4.72K | 6% |
26-Dec-19 4:11 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 24-Dec-19 | Market Sale (Planned) | 7,902 | $16.00 | $126,432.00 | (6%) 135.91K to 128.01K | 52% |
26-Dec-19 10:13 AM View: | Dianthus Therapeutics, Inc.... (DNTH) | 23-Dec-19 | Market Sale (Planned) | 4,181 | $16.03 | $67,021.40 | (3%) 140.09K to 135.91K | 52% |
27-Jun-18 4:30 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 25-Jun-18 | Conversion | 4,643 | -- | -- | 3% 135.45K to 140.09K |